IP Library Granted Patent US 7,022,502
Granted Patent B2
US 7,022,502 · App. 10/169,257 · Granted Apr 4, 2006

Process for the biological production of L-pipecolic acid

Assignee: Mercian Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,022,502
App. No.
10/169,257
Granted
Apr 4, 2006
Kind
B2
Abstract

A process for the production of L-pipecolic acid which comprises the step of reducing delta-1-piperideine-6-carboxylic acid by the use of pyrroline-5-carboxylate reductase. The delta-1-piperideine-6-carboxylic acid is obtained by the step of converting L-lysine by the use of lysine 6-aminotransferase encoded by a gene of Flavobacterium lutescens. The steps of reducing delta-1-piperideine-6-carboxylic acid and the converting of L-lysine into L-pipecolic acid by the use of lysine 6-aminotransferase are carried out by using a bacterium transformed with a gene encoding lysine 6-aminotransferase wherein such bacterium comprises pyrroline-5-carboxylate reductase encoded by a gene of Escherichia coli or a coryneform bacterium. A recombinant bacterium which can be used in this production process is also provided. Thus, the present invention can provide an efficient biological process for the production of L-pipecolic acid (or 2-piperidinecarboxylic acid).

Claims (3)

1. A process for the production of L-pipecolic acid which comprises the step of reducing delta-1-piperideine-6-carboxylic acid by the use of pyrroline-5-carboxylate reductase, wherein the delta-1-piperideine-6-carboxylic acid is obtained by the step of converting L-lysine by the use of lysine 6-aminotransferase encoded by a gene of Flavobacterium lutescens.

2. The process as claimed in claim 1 wherein the pyrroline-5-carboxylate reductase is encoded by a gene of Escherichia coli or a coryneform bacterium.

3. The process as claimed in claim 1 wherein the step of reducing delta-1-piperideine-6-carboxylic acid and the step of converting L-lysine into L-pipecolic acid by the use of lysine 6-aminotransferase are carried out by using a bacterium transformed with a gene encoding lysine 6-aminotransferase wherein such bacterium comprises pyrroline-5-carboxylate reductase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2012
From: MERCIAN CORPORATION
To: MICROBIOPHARM JAPAN CO., LTD.
Reel/Frame 027791/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2002
From: FUJII, TADASHI; ARITOKU, YASUHIDE; MUKAIHARA, MANABU; NARITA, TAKAO; AGEMATU, HITOSI; ISSHIKI, KUNIO
To: MERCIAN CORPORATION
Reel/Frame 013264/0913 →
Priority Claims (1)
JP 11-373389 · Dec 28, 1999 · national
Continuity (1)
Related Publication 20030207410A1 · Nov 6, 2003